If Omicron evades immunity, how will current vaccines still help?

Question

Accepted Answer

Current Vaccines Likely to Mitigate Severe Disease and Death Despite Omicron Evasion

Existing Covid-19 vaccines are still anticipated to offer protection against severe illness and fatalities, even if the Omicron variant proves capable of evading vaccine-induced immunity. This is because the vaccines are designed to elicit a multifaceted immune response that extends beyond simply neutralizing the virus. While Omicron's potential to bypass the antibodies generated by current vaccines is still under investigation, the broader immune mechanisms are expected to remain effective in preventing the most serious outcomes of infection.
Understanding Vaccine-Induced Immunity

Vaccine-induced immunity refers to the protection a person gains after receiving a vaccine. Vaccines work by introducing a harmless component of a pathogen, such as a weakened or inactivated virus, or a specific protein from it, into the body. This prompts the immune system to recognize the pathogen as foreign and develop defenses, including the production of antibodies and specialized immune cells like T-cells. If the vaccinated individual is later exposed to the actual pathogen, their immune system can mount a rapid and effective response, preventing or reducing the severity of illness.
Mechanisms for Reducing Severe Outcomes

Even if Omicron evades the neutralizing antibodies that prevent initial infection, current vaccines are believed to still confer protection through other arms of the immune system. For instance, T-cells, another type of immune cell stimulated by vaccines, can recognize and kill infected cells. This cellular immunity can help clear the virus from the body and prevent it from replicating extensively, thereby reducing the likelihood of severe organ damage and critical illness. Furthermore, the antibodies generated by vaccines, even if less effective at blocking infection by a new variant, might still help slow down viral replication, giving the body's immune system more time to respond and contain the infection.
Ongoing Research and Development

In response to emerging variants like Omicron, China is actively accelerating research and development into new vaccines specifically targeting the variant. Health officials have stated that efforts are underway to advance the development of Omicron-specific vaccines utilizing various technological platforms. While these new vaccines may not ultimately be deployed, the preparation is deemed necessary. Companies such as Sinovac Biotech are evaluating their existing vaccines' efficacy against Omicron and considering the development of new formulations, while BioNTech anticipates having more data within two weeks to assess potential modifications to its vaccine produced with Pfizer Inc.

Reading history

Hide →

This history is cleared when the page is closed.

If Omicron evades immunity, how will current vaccines still help?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends